홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /화합물

아무루비신

Amrubicin

HCID 3035016
새 노트새 반응견적 요청하기
인쇄 미리보기

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보이름 및 식별자물성화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
110267-81-7
표준 SMILES
CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O
InChIKey
VJZITPJGSQKZMX-XDPRQOKASA-N
분자식
C25H25NO9
평균 분자량
483.47 g/mol

이름 및 식별자

우선 이름
Amrubicin
현지명
아무루비신
영어명
Amrubicin
분자식
C25H25NO9
분자량
483.47

이름 및 동의어

아무루비신CS-1168AmrubicinAmurubicin(7S)-9β-Amino-9-acetyl-7β-[(2-deoxy-β-D-erythro-pentopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxynaphthacene-5,12-dione(7S,9S)-9-Acetyl-9-amino-7-[(2-deoxy--D-erythro-pentopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-5,12-naphthacenedione5,12-Naphthacenedione,9-acetyl-9-aMino-7-(2-deoxy-b-D-erythro-pentopyranosyl)oxy-7,8,9,10-tetrahydro-6,11-dihydroxy-,(7S,9S)-(7S,9S)-9-Amino-9-acetyl-7-[(2-deoxy-β-D-erythro-pentopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxynaphthacene-5,12-dione(7S,9S)-9-Acetyl-9-amino-7-(2-deoxy-β-D-erythro-pentopyranosyloxy)-6,11-dihydroxy-5,7,8,9,10,12-hexahydro-5,12-naphthacenedione5,12-Naphthacenedione, 9-acetyl-9-amino-7-[(2-deoxy-β-D-erythro-pentopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-, (7S,9S)-

데이터베이스 식별자

CAS
110267-81-7
PubChem CID
3035016
ChEMBL
CHEMBL1186894
ChEBI
CHEBI:135779
UNII
93N13LB4Z2
Nikkaji
J361.794G

물성

물리화학적 성질

녹는점
172 · 172-1740C
끓는 점
717.8 · 717.8±60.0 °C(Predicted)
밀도
1.6 · 1.60±0.1 g/cm3(Predicted)
저장 조건
-20 °C · Store at -20°C
용해도
16.45 mg/mL · >16.45mg/mL in DMSO
물리적 상태
가루
산도 계수 (pKa)
7.83 · 7.83±0.60(Predicted)
색상
Pink to red

화학 및 산업

응용 분야 · 2건

개요Amrubicin is an active agent for the treatment of small-cell lung cancer (SCLC). It is a type of anthracycline analog. Anthracycline derivatives such as doxorubicin (DXR), daunorubicin (DNR) and epirubicin have been widely used for a variety of carcinomas in the clinical context. Amrubicin is structurally distinguishable from other anthracyclines by the amino group at the 9-position and its unique sugar moiety. In April 2002, Amrubicin was approved in Japan for the treatment of non-small cell lung cancer and small cell lung cancer.

용도Synthetic anthracycline antibiotic; inhibits DNA topoisomerase II. Antineoplastic. Amrubicin is used to treat small-cell lung cancer (SCLC).

추가 설명 · 1건

정의ChEBI: Amrubicin is a synthetic anthracycline antibiotic with molecular formula C25H25NO9. A specific inhibitor of topoisomerase II, it is used (particularly as the hydrochloride salt) in the treatment of cancer, especially lung cancer, where it is a prodrug for the active metabolite, ambrucinol. It has a role as a topoisomerase II inhibitor, an antineoplastic agent and a prodrug. It is a quinone, a member of tetracenes, a methyl ketone, an anthracycline antibiotic and a primary amino compound.

관련 반응

1건
반응 기록 만들기
HRID 842584 반응식
HRID 842584반응물로uspto-grants-2002_04

화합물 노트

불러오는 중…

이 페이지에서기본 정보이름 및 식별자물성화학 및 산업관련 반응화합물 노트
더보기
새 노트새 반응견적 요청하기